Skip to main content
Livermore
Livermore
ZHEN

Creative Planning

SEC CIK
0001540235
Latest filing
Aug 13, 2026

TEVA holding history

Teva Pharmaceutical Industries Ltd in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings

Shares (Q2 2026)
71,019
Value
$2.41M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TEVA by Creative Planning, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202671,019$2.41M<0.1%+6,111+9.4%AddedHolders
Q1 202664,908$1.96M<0.1%+2,072+3.3%AddedHolders
Q4 202562,836$1.96M<0.1%+5,023+8.7%AddedHolders
Q3 202557,813$1.17M<0.1%+1,649+2.9%AddedHolders
Q2 202556,164$941.3K<0.1%+10,784+23.8%AddedHolders
Q1 202545,380$697.5K<0.1%−4,660−9.3%ReducedHolders
Q4 202450,040$1.10M<0.1%+7,225+16.9%AddedHolders
Q3 202442,815$771.5K<0.1%+1,863+4.5%AddedHolders
Q2 202440,952$665.5K<0.1%−568−1.4%ReducedHolders
Q1 202441,520$585.8K<0.1%−1,662−3.8%ReducedHolders
Q4 202343,182$450.8K<0.1%−1,073−2.4%ReducedHolders
Q3 202344,255$451.4K<0.1%−31,451−41.5%ReducedHolders
Q2 202375,706$570.1K<0.1%+3,465+4.8%AddedHolders
Q1 202372,241$639.3K<0.1%−3,722−4.9%ReducedHolders
Q4 202275,963$692.8K<0.1%+1,759+2.4%AddedHolders
Q3 202274,204$599.0K<0.1%+5,941+8.7%AddedHolders
Q2 202268,263$513.0K<0.1%+9,408+16.0%AddedHolders
Q1 202258,855$553.0K<0.1%−25,819−30.5%ReducedHolders
Q4 202184,674$678.0K<0.1%−3,707−4.2%ReducedHolders
Q3 202188,381$861.0K<0.1%−29,044−24.7%ReducedHolders
Q2 2021117,425$1.16M<0.1%−53,139−31.2%ReducedHolders
Q1 2021170,564$1.97M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.